MedPath

PRECISIO BIOTIX THERAPEUTICS INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Phage Therapy for the Prevention and Treatment of Pressure Ulcers.

Phase 1
Conditions
Pressure Ulcer
Interventions
Combination Product: Placebo
Combination Product: Bacteriophage-loaded Microcapsule Spray
Procedure: Standard of Care
First Posted Date
2021-03-25
Last Posted Date
2021-12-21
Lead Sponsor
Precisio Biotix Therapeutics, Inc.
Target Recruit Count
69
Registration Number
NCT04815798

Phage Therapy for the Prevention and Treatment of Wound Infections in Burned Patients

Phase 1
Conditions
Wound Infection
Interventions
Drug: Xeroform
Biological: Bacteriophage cocktail spray
First Posted Date
2020-03-26
Last Posted Date
2021-12-22
Lead Sponsor
Precisio Biotix Therapeutics, Inc.
Target Recruit Count
12
Registration Number
NCT04323475
© Copyright 2025. All Rights Reserved by MedPath